Akebia Therapeutics, Inc. ( AKBA) - Key Metrics

AKBA Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $0.18 -$0.03 $0.01 $0.01
2026Q1 $0.20 -$0.03 -$0.08 -$0.08
2025Q4 $0.22 -$0.05 $0.12 $0.12
2025Q3 $0.22 $0 $0.11 $0.11
2025Q2 $0.24 $0 $0.09 $0.08

AKBA Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% -9.50
2026Q1 0% -10.25
2025Q4 0% -8.73
2025Q3 0% 341.25
2025Q2 0% 1011.11

AKBA Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.80% 0%
2026Q1 -5.71% 0%
2025Q4 7.25% 0%
2025Q3 3.88% 0%
2025Q2 2.32% 0%

AKBA

Price: $0.80

52 week price:
0.80
3.20

Earnings Per Share: -0.12 USD

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 1.3 million

Ebitda: -24.0 million

Market Capitalization: 232.0 million

Links: